Proteolysis-focusing on chimeras (PROTACs) and molecular glue degraders (MGDs) are by far the most maturely produced TPD approaches. With this critique, we center on both preclinical experiments and medical trials to provide an extensive summary of the protection and clinical success of PROTACs and MGDs in hematologic malignancies in the https://dorsomorphin22108.designi1.com/53188284/details-fiction-and-ribavirin